Buy Dr. Reddy's Laboratories; target of Rs 6373 Sharekhan
Sharekhan is bullish on Dr. Reddy's Laboratories has recommended buy rating on the stock with a target price of Rs 6373 in its research report dated December 07, 2023.08-12-2023
08-12-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Dr Reddys Laboratories Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Dr Reddys Laboratories Ltd with respect to news article appearing on https://www.business-standard.com dated December 05, 2023 (Link: https://www.business-standard.com/companies/news/us-regulators-inspect-dr-reddy-s-other-indian-pharma-majors-report-123120500649_1.html) titled "US regulators inspect Dr Reddy''s, other Indian pharma major".Dr Reddys Laboratories Ltd response is enclosed.07-12-2023
Dr Reddy's up 2% after subsidiary collaborates with COYA for ALS drug
Dr Reddy's will make an upfront payment of USD 7.5 million to Coya.07-12-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Clarification sought from Dr Reddys Laboratories Ltd
The Exchange has sought clarification from Dr Reddys Laboratories Ltd with respect to news article appearing on https://www.business-standard.com dated December 05, 2023 (Link: https://www.business-standard.com/companies/news/us-regulators-inspect-dr-reddy-s-other-indian-pharma-majors-report-123120500649_1.html) titled "US regulators inspect Dr Reddy''s, other Indian pharma major".The reply is awaited.06-12-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst / Institutional Investor Meetings01-12-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst/Investor Meet on 04/12/2023 - 05/12/202328-11-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of newspaper publication24-11-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India23-11-2023
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of shares under ESOP/ ESPS21-11-2023